Fecal microbiota transplantation before hematopoietic stem cell transplantation in a pediatric case of chronic diarrhea with a FOXP3 mutation

被引:8
|
作者
Wu, Wenyan [1 ]
Shen, Nan [1 ]
Luo, Lijuan [1 ]
Deng, Zhaohui [2 ]
Chen, Jing [3 ]
Tao, Yue [4 ]
Mo, Xi [4 ]
Cao, Qing [4 ]
机构
[1] Shanghai Jiao Tong Univ, Dept Infect Dis, Shanghai Childrens Med Ctr, Sch Med, Shanghai, Peoples R China
[2] Shanghai Jiao Tong Univ, Dept Gastroenterol, Shanghai Childrens Med Ctr, Sch Med, Shanghai, Peoples R China
[3] Shanghai Jiao Tong Univ, Dept Hematol Oncol, Shanghai Childrens Med Ctr, Shanghai, Peoples R China
[4] Shanghai Jiao Tong Univ, Pediat Translat Med Inst, Shanghai Childrens Med Ctr, Lab Pediat Infect Dis,Sch Med, Shanghai, Peoples R China
来源
PEDIATRICS AND NEONATOLOGY | 2021年 / 62卷 / 02期
基金
中国国家自然科学基金;
关键词
Key Words fecal microbial transplantation; FOXP3gene mutation; hematopoietic stem cell transplantation; iPEX syndrome; CLOSTRIDIUM-DIFFICILE INFECTION; X-LINKED SYNDROME; IMMUNE DYSREGULATION; POLYENDOCRINOPATHY; ENTEROPATHY; CHILDREN; SUCCESS; IPEX;
D O I
10.1016/j.pedneo.2020.11.003
中图分类号
R72 [儿科学];
学科分类号
100202 ;
摘要
Background: Immune dysregulation, polyendocrinopathy, enteropathy, X-linked (IPEX) syndrome is a rare disorder caused by mutation of the forkhead box protein 3 (FOXP3) gene, often leading to intractable and life-threatening diarrhea. Fecal microbiota transplantation (FMT), has been regarded in recent years as an available approach to reconstruct disrupted gut micro biome and successfully used to attenuates diarrhea induced by different underlying diseases. Therefore, FMT may have curative potential on the symptoms of enteropathy in patients with IPEX syndrome. Methods: Physical and laboratory examinations were performed, and clinical data were collected. FMT was administered via frozen fecal microbial solution, and the fecal microbiota composition was analyzed using 16S rDNA sequencing before and after FMT. Results: The patient was diagnosed with IPEX syndrome with a mutation detected in the FOXP3 gene, which was identified as c.767T > C (p.M256T). He presented with recurrent watery diarrhea and respiratory infections after birth and developed a significant failure to thrive. Disturbances in the gut microbiota composition and marked decreased bacterial diversity were observed to be involved in the persistent and refractory diarrhea. After receiving FMT treatment, the patient responded with remission of the diarrhea without apparent side effects. His stool output significantly decreased, corresponding to increased microbial diversity and modification of his microbiota composition. The patient finally achieved full recovery after hematopoietic stem cell transplantation (HSCT). Conclusion: Our data suggest an association between the gut microbiota and clinical symptoms of patient with IPEX syndrome and demonstrate FMT as an alternative therapy for severe diarrhea unresponsive to routine therapy in these patients. Copyright & ordf; 2020, Taiwan Pediatric Association. Published by Elsevier Taiwan LLC. This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/ by-nc-nd/4.0/).
引用
收藏
页码:172 / 180
页数:9
相关论文
共 50 条
  • [21] Fecal Microbiota Transplantation in a Domestic Ferret Suffering from Chronic Diarrhea and Maldigestion-Fecal Microbiota and Clinical Outcome: A Case Report
    Ravel, Sean J.
    Hollifield, Victoria M.
    VETERINARY MEDICINE-RESEARCH AND REPORTS, 2024, 15 : 171 - 180
  • [22] FOXP3 expression in CD4+CD25+T cells after human hematopoietic stem cell transplantation
    Siedel, MG
    Juergens, B
    Ernst, U
    Printz, D
    Gadner, H
    Heitger, A
    PEDIATRIC TRANSPLANTATION, 2005, 9 : 56 - 56
  • [23] The Effects of Fecal Donors with Different Feeding Patterns on Diarrhea in a Patient Undergoing Hematopoietic Stem Cell Transplantation
    Zhang, Jianping
    Ren, Guangxu
    Li, Minghua
    Lu, Peihua
    Yi, Suqin
    CASE REPORTS IN HEMATOLOGY, 2019,
  • [24] Clinical outcomes of fecal microbiota transplantation for overcoming multidrug resistant infection complications after haploidentical hematopoietic stem cell transplantation
    Goloschapov, O.
    Kucher, M.
    Suvorova, M.
    Klementeva, R.
    Shcherbakov, A.
    Shvetcov, A.
    Chukhlovin, A.
    Afanasyev, B.
    BONE MARROW TRANSPLANTATION, 2017, 52 : S243 - S244
  • [25] The clinical role of the gut microbiome and fecal microbiota transplantation in allogeneic stem cell transplantation
    Henig, Israel
    Yehudai-Ofir, Dana
    Zuckerman, Tsila
    HAEMATOLOGICA, 2021, 106 (04) : 933 - 946
  • [26] Efficacy and Safety of Fecal Microbiota Transplantation in the Treatment of Chronic Steroid-Refractory Graft-Versus-Host Disease after Hematopoietic Stem Cell Transplantation
    Huang, Fen
    Du, Jing
    Lv, Pinjing
    Yang, Kaibo
    Fan, Zhiping
    Xuan, Li
    Sun, Jing
    Xu, Na
    Liu, Hui
    Shi, Pengcheng
    Li, Xiaofang
    Xu, Jun
    Wang, Zhixiang
    Wang, Pu
    Yao, Xiang
    Chen, Ye
    Liu, Qifa
    BLOOD, 2023, 142
  • [27] Recognizing a Non-classical Telomeropathy before Hematopoietic Stem Cell Transplantation in Pediatric Patients: A Case Series
    Nederlof, Iris
    Lindemans, Caroline A.
    Bierings, Marc B.
    Mohseny, Alexander B.
    Bresters, Dorine
    Bartels, Marije
    HEMASPHERE, 2019, 3 (04):
  • [28] Expression of the putatively regulatory T-cell marker FOXP3 by CD4+CD25+ T cells after pediatric hematopoietic stem cell transplantation
    Seidel, Markus G.
    Ernst, Ursula
    Printz, Dieter
    Juergens, Birgit
    Pichler, Josefa
    Attarbaschi, Andishe
    Fritsch, Gerhard
    Gadner, Helmut
    Heitger, Andreas
    HAEMATOLOGICA, 2006, 91 (04) : 566 - 569
  • [29] Antibiotic-Induced Shifts in Fecal Microbiota Density and Composition during Hematopoietic Stem Cell Transplantation
    Morjaria, Sejal
    Schluter, Jonas
    Taylor, Bradford P.
    Littmann, Eric R.
    Carter, Rebecca A.
    Fontana, Emily
    Peled, Jonathan U.
    van den Brink, Marcel R. M.
    Xavier, Joao B.
    Taur, Ying
    INFECTION AND IMMUNITY, 2019, 87 (09)
  • [30] Sequelae of pediatric allogeneic hematopoietic stem cell transplantation
    Diamond, C.
    Oeffinger, K.
    Hall, R.
    Driscoll, T.
    Cardones, A.
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2022, 142 (08) : B10 - B10